OptiNose Statistics
Total Valuation
OptiNose has a market cap or net worth of $134.06 million. The enterprise value is $190.60 million.
| Market Cap | 134.06M |
| Enterprise Value | 190.60M |
Important Dates
The next estimated earnings date is Thursday, May 9, 2024, before market open.
| Earnings Date | May 9, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
OptiNose has 112.65 million shares outstanding. The number of shares has increased by 30.48% in one year.
| Shares Outstanding | 112.65M |
| Shares Change (YoY) | +30.48% |
| Shares Change (QoQ) | +0.09% |
| Owned by Insiders (%) | 8.97% |
| Owned by Institutions (%) | 77.60% |
| Float | 82.48M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.89 |
| Forward PS | 1.44 |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.68 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.60
| Current Ratio | 0.60 |
| Quick Ratio | 0.53 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -0.82 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -33.00% |
| Return on Capital (ROIC) | -52.15% |
| Revenue Per Employee | $537,780 |
| Profits Per Employee | -$268,811 |
| Employee Count | 132 |
| Asset Turnover | 0.66 |
| Inventory Turnover | 0.99 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -41.95% in the last 52 weeks. The beta is -0.24, so OptiNose's price volatility has been lower than the market average.
| Beta (1Y) | -0.24 |
| 52-Week Price Change | -41.95% |
| 50-Day Moving Average | 1.52 |
| 200-Day Moving Average | 1.30 |
| Relative Strength Index (RSI) | 26.52 |
| Average Volume (30 Days) | 569,095 |
Short Selling Information
The latest short interest is 3.11 million, so 2.76% of the outstanding shares have been sold short.
| Short Interest | 3.11M |
| Short Previous Month | 3.20M |
| Short % of Shares Out | 2.76% |
| Short % of Float | 3.77% |
| Short Ratio (days to cover) | 3.20 |
Income Statement
In the last 12 months, OptiNose had revenue of $70.99 million and -$35.48 million in losses. Loss per share was -$0.32.
| Revenue | 70.99M |
| Gross Profit | 62.35M |
| Operating Income | -22.75M |
| Pretax Income | -35.48M |
| Net Income | -35.48M |
| EBITDA | -15.55M |
| EBIT | -15.96M |
| Loss Per Share | -$0.32 |
Balance Sheet
The company has $73.68 million in cash and $130.23 million in debt, giving a net cash position of -$56.54 million or -$0.50 per share.
| Cash & Cash Equivalents | 73.68M |
| Total Debt | 130.23M |
| Net Cash | -56.54M |
| Net Cash Per Share | -$0.50 |
| Equity / Book Value | -86.61M |
| Book Value Per Share | -0.77 |
| Working Capital | -71.19M |
Cash Flow
In the last 12 months, operating cash flow was -$20.53 million and capital expenditures -$328,000, giving a free cash flow of -$20.86 million.
| Operating Cash Flow | -20.53M |
| Capital Expenditures | -328,000 |
| Free Cash Flow | -20.86M |
| FCF Per Share | -$0.19 |
Margins
Gross margin is 87.84%, with operating and profit margins of -32.05% and -49.99%.
| Gross Margin | 87.84% |
| Operating Margin | -32.05% |
| Pretax Margin | -49.99% |
| Profit Margin | -49.99% |
| EBITDA Margin | -21.91% |
| EBIT Margin | -22.48% |
| FCF Margin | -29.39% |
Dividends & Yields
OptiNose does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -30.48% |
| Shareholder Yield | -30.48% |
| Earnings Yield | -26.47% |
| FCF Yield | -15.56% |
Analyst Forecast
The average price target for OptiNose is $4.00, which is 236.13% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $4.00 |
| Price Target Difference | 236.13% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 37.05% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
OptiNose has an Altman Z-Score of -9.57 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -9.57 |
| Piotroski F-Score | 2 |